Form F-1/A Link: https://t.co/RQcYLFMXQO
Okay hope everyone having a lovely weekend. Lots of love today. Feeling very blessed 🥰 Going through NNOX tweets from last week. Time to compile threads and bring you highlights. No need to go digging old tweets if I do for you 🤗 FDA, Secondary, and 3P510k. Let’s review..
Form F-1/A Link: https://t.co/RQcYLFMXQO
Reference to Eagle eyes: https://t.co/gT779MFX82
We discover in F-1 that 3P510K recommended clearance of Nanox Source. This triggers a 30 day timeline to approval by FDA. However ...
Eagle-eyes \U0001f985 https://t.co/w1wF3Ysmt1
— Harvey \U0001f1fa\U0001f1f8 (@realharveymark) February 12, 2021
The short thesis destroyed by the recommend clearance. Go back see where NNOX trade before short report. You will recognize the number. Okay you see the number approx the analyst price targets and secondary pricing.
NNOX here\u2019s a link about FDA Third Party Review Program. https://t.co/hlrrlXi6Us
— Harvey \U0001f1fa\U0001f1f8 (@realharveymark) February 11, 2021
"The FDA's review timeframe for a MDUFA decision is within 30 days after receiving the recommendation of a 3P510k Review Organization."
I typo 99 mean pg 97 but this covered in F-1. Nanox has mapped this out fully and tell you exactly what to expect.
These are two important NNOX points. 3P510K 30 day, FDA classification decision covered for you
The \u201cde novo\u201d process is a risk-based classification determination means low to moderate risk novel medical devices can have route to market. Okay this is contingency talk. This is a short seller dream scenario. FUD gonna get all over everything but not you. You go to F-1/A pg 99
— Harvey \U0001f1fa\U0001f1f8 (@realharveymark) February 11, 2021
Tomorrow FDA will publish all approvals that occur last week. It very possible NNOX is there. Maybe 60% chance
30 days \U0001f60e https://t.co/Qj80xn00pI
— Harvey \U0001f1fa\U0001f1f8 (@realharveymark) February 12, 2021
More from Life
Always. No, your company is not an exception.
A tactic I don’t appreciate at all because of how unfairly it penalizes low-leverage, junior employees, and those loyal enough not to question it, but that’s negotiation for you after all. Weaponized information asymmetry.
Listen to Aditya
"we don't negotiate salaries" really means "we'd prefer to negotiate massive signing bonuses and equity grants, but we'll negotiate salary if you REALLY insist" https://t.co/80k7nWAMoK
— Aditya Mukerjee, the Otterrific \U0001f3f3\ufe0f\u200d\U0001f308 (@chimeracoder) December 4, 2018
And by the way, you should never be worried that an offer would be withdrawn if you politely negotiate.
I have seen this happen *extremely* rarely, mostly to women, and anyway is a giant red flag. It suggests you probably didn’t want to work there.
You wish there was no negotiating so it would all be more fair? I feel you, but it’s not happening.
Instead, negotiate hard, use your privilege, and then go and share numbers with your underrepresented and underpaid colleagues. […]
You May Also Like
Why is this the most powerful question you can ask when attempting to reach an agreement with another human being or organization?
A thread, co-written by @deanmbrody:
Next level tactic when closing a sale, candidate, or investment:
— Erik Torenberg (@eriktorenberg) February 27, 2018
Ask: \u201cWhat needs to be true for you to be all in?\u201d
You'll usually get an explicit answer that you might not get otherwise. It also holds them accountable once the thing they need becomes true.
2/ First, “X” could be lots of things. Examples: What would need to be true for you to
- “Feel it's in our best interest for me to be CMO"
- “Feel that we’re in a good place as a company”
- “Feel that we’re on the same page”
- “Feel that we both got what we wanted from this deal
3/ Normally, we aren’t that direct. Example from startup/VC land:
Founders leave VC meetings thinking that every VC will invest, but they rarely do.
Worse over, the founders don’t know what they need to do in order to be fundable.
4/ So why should you ask the magic Q?
To get clarity.
You want to know where you stand, and what it takes to get what you want in a way that also gets them what they want.
It also holds them (mentally) accountable once the thing they need becomes true.
5/ Staying in the context of soliciting investors, the question is “what would need to be true for you to want to invest (or partner with us on this journey, etc)?”
Multiple responses to this question are likely to deliver a positive result.